Warning! GuruFocus has detected 1 Severe warning sign with MEDP. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for MEDP (Medpace Holdings Inc) from 2016 to Apr 16 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Medpace stock (MEDP) PE ratio as of Apr 16 2021 is 48.17. More Details
Medpace PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Medpace PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin America.